By Ken Schachter | September 2, 2021

A Stony Brook company whose human COVID-19 vaccine was repurposed to treat cats has pivoted to a more promising animal market: mink farms.

Applied DNA Sciences Inc. expects to begin the new animal trials in upstate Brewster this month, a company spokesman said.

Mink, however, will not be used to test the vaccine. Instead, the trials will use ferrets because uninfected mink are scarce.